Arrhythmias News

  • 'Recalled' Riata: Brainstorming Conference Aims for Guidance The lead failures can take years to manifest with inappropriate shocks or a variety of other issues, or they may not cause problems at all. There could be more agreement on how to manage the patients after today's Minnesota Heart Institute Riata ICD Lead Summit.
  • BAFS Dronedarone Gets Another Chance in Ranolazine Combo Trial Researchers of the beleaguered antiarrhythmic dronedarone believe the drug may still have a role to play in AF therapy for some patients and are testing it as a low-dose compliment to another newer antiarrhythmic drug, ranolazine.
 

Arrhythmias Perspectives

 

Arrhythmias Journal Articles

 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.